Axl Receptor Axis: A New Therapeutic Target in Lung Cancer.
about
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFRInstitutional implementation of clinical tumor profiling on an unselected cancer population.Pharmacological management of relapsed/refractory NSCLC with chemical drugs.Function of Axl receptor tyrosine kinase in non-small cell lung cancer.Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.
P2860
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer.
@en
type
label
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer.
@en
prefLabel
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer.
@en
P2093
P2860
P1476
Axl Receptor Axis: A New Therapeutic Target in Lung Cancer
@en
P2093
Lauren Averett Byers
Pavel A Levin
Rolf A Brekken
P2860
P304
P356
10.1016/J.JTHO.2016.04.015
P577
2016-04-26T00:00:00Z